{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:15:12Z","timestamp":1768868112417,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"publisher","award":["JCYJ20220818100801002"],"award-info":[{"award-number":["JCYJ20220818100801002"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SIAT Innovation Program for Excellent Young","award":["E1G023"],"award-info":[{"award-number":["E1G023"]}]},{"name":"Shenzhen Key Laboratory of Viral Vectors for Biomedicine","award":["ZDSYS20200811142401005"],"award-info":[{"award-number":["ZDSYS20200811142401005"]}]},{"name":"Key Laboratory of Quality Control Technology for Virus-Based Therapeutics","award":["2020ZDB26"],"award-info":[{"award-number":["2020ZDB26"]}]},{"name":"Key Laboratory of Quality Control Technology for Virus-Based Therapeutics","award":["2022ZDZ13"],"award-info":[{"award-number":["2022ZDZ13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Feline herpesvirus type 1 (FHV-1), a member of the <jats:italic>Herpesviridae<\/jats:italic> family, is one of the most important pathogens that causes upper respiratory tract disease in felines. Following infection, FHV-1 can spread retrogradely to the trigeminal ganglia, establishing a life-long latency. Although vaccines are available for routine feline vaccination, FHV-1 is still an agent that poses a serious threat to feline health. There are currently no specific drugs for the treatment of FHV-1. To facilitate the screening of antiviral drugs, we constructed a reporter FHV-1 virus, which expresses a secreted Gaussia luciferase (GLuc) and a bright green fluorescent protein, mNeonGreen. The reporter virus shows slower growth than does the wild-type FHV-1. The expression of the two reporter genes, Gluc and mNeonGreen, was consistent with viral propagation and remained stable during continuous passage in CRFK cells, even after twenty rounds. In addition, the known inhibitor ganciclovir was used to confirm the characteristics of the reporter virus for drug screening. We found that the reporter FHV-1 is suitable for antiviral screening assays. Overall, our work provides a useful tool for screening drugs to combat FHV-1.<\/jats:p>","DOI":"10.1186\/s13567-024-01430-7","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:10:51Z","timestamp":1734520251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a reporter feline herpesvirus-1 for antiviral screening assays"],"prefix":"10.1186","volume":"55","author":[{"given":"Jia","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-5556","authenticated-orcid":false,"given":"Fan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1051\/vetres:2006063","volume":"38","author":"R Gaskell","year":"2007","unstructured":"Gaskell R, Dawson S, Radford A, Thiry E (2007) Feline herpesvirus. Vet Res 38:337\u2013354","journal-title":"Vet Res"},{"key":"1430_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jfms.2009.05.003","volume":"11","author":"E Thiry","year":"2009","unstructured":"Thiry E, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Truyen U, Horzinek MC (2009) Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 11:547\u2013555","journal-title":"J Feline Med Surg"},{"key":"1430_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.vetmic.2009.03.022","volume":"138","author":"M Richter","year":"2009","unstructured":"Richter M, Schudel L, Tobler K, Matheis F, Vogtlin A, Vanderplasschen A, Costes B, Spiess B, Ackermann M (2009) Clinical, virological, and immunological parameters associated with superinfection of latently with FeHV-1 infected cats. Vet Microbiol 138:205\u2013216","journal-title":"Vet Microbiol"},{"key":"1430_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2023.109728","volume":"281","author":"M Yang","year":"2023","unstructured":"Yang M, Jiao Y, Yan Y, Li L, Hu X, Jiao Z, Li M, Chen Y, Shi Y, Shen Z, Peng G (2023) Safety and immunogenicity of a TK\/ gI\/gE gene-deleted feline herpesvirus-1 mutant constructed via CRISPR\/Cas9 in feline. Vet Microbiol 281:109728","journal-title":"Vet Microbiol"},{"key":"1430_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/v13020163","volume":"13","author":"Y Lee","year":"2021","unstructured":"Lee Y, Maes RK, Kruger JM, Kiupel M, Giessler KS, Soboll Hussey G (2021) Safety and efficacy of felid herpesvirus-1 deletion mutants in cats. Viruses 13:163","journal-title":"Viruses"},{"key":"1430_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12985-023-02053-8","volume":"20","author":"A Tang","year":"2023","unstructured":"Tang A, Zhu M, Zhu J, Zhang D, Zhu S, Wang X, Meng C, Li C, Liu G (2023) Pathogenicity and immunogenicity of gI\/gE\/TK-gene-deleted Felid herpesvirus 1 variants in cats. Virol J 20:87","journal-title":"Virol J"},{"key":"1430_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1006\/viro.1995.9959","volume":"214","author":"MD Sussman","year":"1995","unstructured":"Sussman MD, Maes RK, Kruger JM, Spatz SJ, Venta PJ (1995) A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis. Virology 214:12\u201320","journal-title":"Virology"},{"key":"1430_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/v13071228","volume":"13","author":"LA Sadowski","year":"2021","unstructured":"Sadowski LA, Upadhyay R, Greeley ZW, Margulies BJ (2021) Current drugs to treat infections with herpes simplex viruses-1 and -2. Viruses 13:1228","journal-title":"Viruses"},{"key":"1430_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1746-6148-2-13","volume":"2","author":"K van der Meulen","year":"2006","unstructured":"van der Meulen K, Garre B, Croubels S, Nauwynck H (2006) In vitro comparison of antiviral drugs against feline herpesvirus 1. BMC Vet Res 2:13","journal-title":"BMC Vet Res"},{"key":"1430_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/vop.12375","volume":"19","author":"SM Thomasy","year":"2016","unstructured":"Thomasy SM, Maggs DJ (2016) A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1. Vet Ophthalmol 19:119\u2013130","journal-title":"Vet Ophthalmol"},{"key":"1430_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.neuron.2011.12.002","volume":"72","author":"L Lo","year":"2011","unstructured":"Lo L, Anderson DJ (2011) A Cre-dependent, anterograde transsynaptic viral tracer for mapping output pathways of genetically marked neurons. Neuron 72:938\u2013950","journal-title":"Neuron"},{"key":"1430_CR12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.016571","volume":"296","author":"KM Scherer","year":"2021","unstructured":"Scherer KM, Manton JD, Soh TK, Mascheroni L, Connor V, Crump CM, Kaminski CF (2021) A fluorescent reporter system enables spatiotemporal analysis of host cell modification during herpes simplex virus-1 replication. J Biol Chem 296:100236","journal-title":"J Biol Chem"},{"key":"1430_CR13","doi-asserted-by":"publisher","first-page":"eadk9185","DOI":"10.1126\/sciadv.adk9185","volume":"10","author":"JP Fredrikson","year":"2024","unstructured":"Fredrikson JP, Domanico LF, Pratt SL, Loveday EK, Taylor MP, Chang CB (2024) Single-cell herpes simplex virus type 1 infection of neurons using drop-based microfluidics reveals heterogeneous replication kinetics. Sci Adv 10:eadk9185","journal-title":"Sci Adv"},{"key":"1430_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnana.2019.00063","volume":"13","author":"F Jia","year":"2019","unstructured":"Jia F, Lv P, Miao H, Shi X, Mei H, Li L, Xu X, Tao S, Xu F (2019) Optimization of the fluorescent protein expression level based on pseudorabies virus bartha strain for neural circuit tracing. Front Neuroanat 13:63","journal-title":"Front Neuroanat"},{"key":"1430_CR15","doi-asserted-by":"publisher","first-page":"9264","DOI":"10.1073\/pnas.97.16.9264","volume":"97","author":"BN Smith","year":"2000","unstructured":"Smith BN, Banfield BW, Smeraski CA, Wilcox CL, Dudek FE, Enquist LW, Pickard GE (2000) Pseudorabies virus expressing enhanced green fluorescent protein: a tool for in vitro electrophysiological analysis of transsynaptically labeled neurons in identified central nervous system circuits. Proc Natl Acad Sci USA 97:9264\u20139269","journal-title":"Proc Natl Acad Sci USA"},{"key":"1430_CR16","doi-asserted-by":"publisher","first-page":"10106","DOI":"10.1128\/JVI.77.18.10106-10112.2003","volume":"77","author":"BW Banfield","year":"2003","unstructured":"Banfield BW, Kaufman JD, Randall JA, Pickard GE (2003) Development of pseudorabies virus strains expressing red fluorescent proteins: new tools for multisynaptic labeling applications. J Virol 77:10106\u201310112","journal-title":"J Virol"},{"key":"1430_CR17","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/v14040826","volume":"14","author":"MG Lloyd","year":"2022","unstructured":"Lloyd MG, Yee MB, Flot JS, Liu D, Geiler BW, Kinchington PR, Moffat JF (2022) Development of robust varicella zoster virus luciferase reporter viruses for in vivo monitoring of virus growth and its antiviral inhibition in culture, skin, and humanized mice. Viruses 14:826","journal-title":"Viruses"},{"key":"1430_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.536150","volume":"10","author":"U Rand","year":"2020","unstructured":"Rand U, Kubsch T, Kasmapour B, Cicin-Sain L (2020) A novel triple-fluorescent HCMV strain reveals gene expression dynamics and anti-herpesviral drug mechanisms. Front Cell Infect Microbiol 10:536150","journal-title":"Front Cell Infect Microbiol"},{"key":"1430_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.virol.2016.01.001","volume":"490","author":"F Jia","year":"2016","unstructured":"Jia F, Zhu X, Xu F (2016) A single adaptive point mutation in Japanese encephalitis virus capsid is sufficient to render the virus as a stable vector for gene delivery. Virology 490:109\u2013118","journal-title":"Virology"},{"key":"1430_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104939","volume":"183","author":"R Sanchez-Velazquez","year":"2020","unstructured":"Sanchez-Velazquez R, de Lorenzo G, Tandavanitj R, Setthapramote C, Bredenbeek PJ, Bozzacco L, MacDonald MR, Clark JJ, Rice CM, Patel AH, Kohl A, Varjak M (2020) Generation of a reporter yellow fever virus for high throughput antiviral assays. Antiviral Res 183:104939","journal-title":"Antiviral Res"},{"key":"1430_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nmeth.2413","volume":"10","author":"NC Shaner","year":"2013","unstructured":"Shaner NC, Lambert GG, Chammas A, Ni Y, Cranfill PJ, Baird MA, Sell BR, Allen JR, Day RN, Israelsson M, Davidson MW, Wang J (2013) A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nat Methods 10:407\u2013409","journal-title":"Nat Methods"},{"key":"1430_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ymthe.2004.10.016","volume":"11","author":"BA Tannous","year":"2005","unstructured":"Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11:435\u2013443","journal-title":"Mol Ther"},{"key":"1430_CR23","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.1021\/ac901234r","volume":"81","author":"CA Maguire","year":"2009","unstructured":"Maguire CA, Deliolanis NC, Pike L, Niers JM, Tjon-Kon-Fat LA, Sena-Esteves M, Tannous BA (2009) Gaussia luciferase variant for high-throughput functional screening applications. Anal Chem 81:7102\u20137106","journal-title":"Anal Chem"},{"key":"1430_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105272","volume":"201","author":"KY Chen","year":"2022","unstructured":"Chen KY, Krischuns T, Varga LO, Harigua-Souiai E, Paisant S, Zettor A, Chiaravalli J, Delpal A, Courtney D, O\u2019Brien A, Baker SC, Decroly E, Isel C, Agou F, Jacob Y, Blondel A, Naffakh N (2022) A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5\/3CLpro inhibitors. Antiviral Res 201:105272","journal-title":"Antiviral Res"},{"key":"1430_CR25","doi-asserted-by":"publisher","DOI":"10.3791\/59626","author":"P Dhungel","year":"2019","unstructured":"Dhungel P, Cantu F, Hernandez C, Yang Z (2019) In vitro transcribed RNA-based luciferase reporter assay to study translation regulation in poxvirus-infected cells. J Vis Exp 147:e59626","journal-title":"J Vis Exp"},{"key":"1430_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab121","volume":"49","author":"I Kisly","year":"2021","unstructured":"Kisly I, Kattel C, Remme J, Tamm T (2021) Luciferase-based reporter system for in vitro evaluation of elongation rate and processivity of ribosomes. Nucleic Acids Res 49:e59","journal-title":"Nucleic Acids Res"},{"key":"1430_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41467-023-44501-7","volume":"15","author":"J Koppke","year":"2024","unstructured":"Koppke J, Keller LE, Stuck M, Arnow ND, Bannert N, Doellinger J, Cingoz O (2024) Direct translation of incoming retroviral genomes. Nat Commun 15:299","journal-title":"Nat Commun"},{"key":"1430_CR28","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1128\/JVI.78.15.8159-8171.2004","volume":"78","author":"M Tilgner","year":"2004","unstructured":"Tilgner M, Shi PY (2004) Structure and function of the 3\u2019 terminal six nucleotides of the West Nile virus genome in viral replication. J Virol 78:8159\u20138171","journal-title":"J Virol"},{"key":"1430_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/jop.2022.0001","volume":"38","author":"EC Ledbetter","year":"2022","unstructured":"Ledbetter EC, Badanes ZI, Chan RX, Donohue LK, Hayot NL, Harman RM, Van de Walle GR, Mohammed HO (2022) Comparative efficacy of topical ophthalmic ganciclovir and oral famciclovir in cats with experimental ocular feline herpesvirus-1 epithelial infection. J Ocul Pharmacol Ther 38:339\u2013347","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-024-01430-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-024-01430-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-024-01430-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:15:35Z","timestamp":1734524135000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryresearch.biomedcentral.com\/articles\/10.1186\/s13567-024-01430-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1186\/s13567-024-01430-7","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}